Downregulated leukocyte cell-derived chemotaxin 2 (LECT2) is a direct target of Wnt/β-catenin signaling in HCC and could be a potential biomarker of HCC in patients [55,56]. The gene discussed is LECT2; the disease is hepatocellular carcinoma.